Point-of-Care Testing Devices Market is projected to reach USD 101.51 billion by 2033 | Siemens Healthcare, Danaher Corporation, SEKISUI Diagnostics, Trinity Biotech, Beckman Coulter Inc, Nova Biomedical

The global Point-of-Care Testing (POCT) Devices Market was valued at USD 49.73 billion in 2024 and is projected to reach approximately USD 101.51 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.6% during the forecast period 2025 to 2033.

The Point-of-Care Testing Devices Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/point-of-care-testing-devices-market?sg

Point-of-Care Testing Devices Market Overview:

Point-of-Care Testing (POCT) refers to medical diagnostic testing conducted at or near the location of the patient, enabling rapid results that can directly influence immediate clinical decisions. Unlike conventional laboratory testing, which often requires sending samples to centralized labs and waiting extended periods for results, POCT offers near-instant feedback. This facilitates faster diagnosis, more timely treatments, and improved patient outcomes.

POCT includes a diverse array of tools and technologies, such as portable analyzers, handheld devices, and diagnostic kits. Common applications include glucose monitoring, rapid strep and flu tests, and at-home pregnancy tests. These tests are widely used across various settings ranging from hospitals and clinics to pharmacies and even patient homes improving the accessibility and efficiency of healthcare services.

Technological progress is playing a central role in driving market expansion. Innovations in miniaturization, connectivity, and accuracy have made POCT devices more reliable and user-friendly. For example, in a notable development, Masimo's MightySat Medical recently received FDA clearance, making it the first over-the-counter fingertip pulse oximeter approved for consumer use without a prescription. The device incorporates Masimo SET® pulse oximetry, a clinically proven technology used by healthcare professionals worldwide to monitor more than 200 million patients annually.

Point-of-Care Testing Devices Industry Trends:

Technological Advancements Driving Market Growth

Technological innovation is a key driver behind the continued expansion of the global point-of-care testing (POCT) devices market. As the healthcare industry shifts toward faster and more accessible diagnostic tools, advancements in technology are playing a crucial role in meeting these demands. Breakthroughs in areas such as biosensors, microfluidics, and lab-on-a-chip technologies have significantly improved diagnostic speed, accuracy, and usability, enabling better patient outcomes across various care settings.

For instance, in September 2024, Abbott Laboratories introduced its Lingo continuous glucose monitor for over-the-counter use in the U.S. The device is designed to help users monitor and better understand glucose spikes sudden increases and drops in blood sugar levels-which can inform healthier lifestyle choices and preventive care strategies.

Additionally, in August 2024, DEXIS launched DEXIS Connect Pro, a smart service platform for its CBCT and intraoral sensor devices. Leveraging Internet of Things (IoT) technology, the system continuously monitors device performance to proactively detect issues and initiate service support when necessary. This innovation helps dental practices minimize downtime and maintain uninterrupted patient care.

These advancements not only enhance the capabilities of POCT devices but also contribute to improved workflow efficiency, user satisfaction, and overall healthcare delivery.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/point-of-care-testing-devices-market?sg

Strategic Players Driving the Point-of-Care Testing Devices Market: Abbott, F. Hoffmann-La Roche, BD, Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Danaher Corporation, SEKISUI Diagnostics, Trinity Biotech, Beckman Coulter, Inc., Nova Biomedical.

Research Methodology:

The global Point-of-Care Testing Devices Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Point-of-Care Testing Devices Market:

By Product (Glucose Monitoring Products, Infectious Disease Testing Products, Pregnancy and Fertility Testing Products, Tumor/Cancer Marker Testing Products, Hematology Testing Products, Others)

By Application (Blood Transfusion, Cardiac Monitoring, Blood Glucose, Haematology, Non-Invasive SPO2 and CO2 Monitoring, Others)

By Testing Type (Immunoassays, Cell-Based Assays, Nucleic Acid Amplification Testing, Clinical Chemistry Assays, Hematology, Others)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Recent Developments:

✅ In January 2023, Cipla launched Cippoint, an advanced point-of-care testing device designed to deliver rapid and accurate diagnostic results across a broad spectrum of health conditions. The system supports testing for cardiac markers, diabetes, infectious diseases, fertility issues, thyroid function, inflammation, metabolic conditions, and coagulation disorders. The device has received CE IVD certification, confirming compliance with the European In Vitro Diagnostic Device Directive and reinforcing its reliability for clinical use.

✅ In November 2024, Caris Life Sciences received U.S. FDA approval for MI Cancer Seek, a novel companion diagnostic (CDx) assay. This approval allows the test to be used in identifying cancer patients who are most likely to benefit from targeted therapies. The assay includes a pan-cancer indication along with five tumor-specific markers, supporting personalized treatment decisions across multiple FDA-approved cancer therapies.

Regional Analysis for Point-of-Care Testing Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Point-of-Care Testing Devices Market Research Industry:

➠ Who leads the Point-of-Care Testing Devices industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Point-of-Care Testing Devices market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Point-of-Care Testing Devices market growth?

➠ What are the dominant sales and distribution strategies in the Point-of-Care Testing Devices industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.